Skip to main content Help with accessibility Skip to main navigation

Dabigatran

Indication

Treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism (NICE TA327)
NICE TA327 - Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism
Amber level 0

Brand:

Pradaxa ®

Nice TA:

327

Commissioning responsibility:

CCG

PbR excluded:

No

BNF chapter:
Cardiovascular system

Background

Recommendation

LSCMMG Recommendation:

Amber level 0

Reason for decision:

Suitable for GP prescribing following recommendation/initiation by specialist

Supporting documents:

Decisions of Lancashire local decision making groups

Pending
Pending
Amber 0
Pending
Amber 0
Amber 0
Amber 0
Pending
What do the colours mean?

Last Updated: 01 - Jan - 2015